Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Authors: Man Sun, Dan Zang, Jun Chen
Format: Artículo Open Access
Published: Wiley 2026
Subjects:
Diabetes, Obesity and Metabolism
Online Access:https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.70710
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View
Description
DOI:10.1111/dom.70710

Similar Items

  • HbA1c ≤ 6.5% in Early Type 2 Diabetes: Threshold, Trajectory, or Marker of Integrated Risk Management?
    by: Man Sun, et al.
    Published: (2026)
  • Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity
    by: Andreea Ciudin, et al.
    Published: (2026)
  • Comment on ‘Semaglutide and Tirzepatide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World ( STEER )’
    by: Chih‐Yuan Wang
    Published: (2026)
  • Real‐World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non‐Diabetic Adults
    by: Mai Katsura, et al.
    Published: (2026)
  • The cost‐utility and budget impact analyses of Tirzepatide versus once‐weekly Semaglutide as add‐on therapy to metformin in patients with type 2 diabetes mellitus in China
    by: Sihua Wang, et al.
    Published: (2025)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs